Lanzul (Lansoprazole)

Lansoprazole works by irreversibly inhibiting the gastric H+/K+ ATPase pump in the parietal cells of the stomach. This blockade stops the final step of acid secretion, leading to a sustained increase in gastric pH and allowing ulcerated tissue to heal while relieving acid‑related symptoms.

The appropriate dose of Lanzul is determined by a qualified prescriber based on the specific condition, severity, and patient characteristics. Dosage may vary for GERD, ulcer disease, or H. pylori therapy, and the prescribing information should be followed exactly.

Safety data for lansoprazole during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual risk factors before prescribing.

To order Lanzul, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lanzul (lansoprazole) belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs like omeprazole, lansoprazole has a similar efficacy profile but may differ slightly in metabolism and drug‑interaction potential.

Lanzul should be stored at room temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Lanzul is taken orally, usually as a whole tablet with a glass of water. It is commonly recommended to take the dose before a meal, but patients should follow the specific instructions provided by their prescriber or the product label.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels (hypomagnesemia), and interstitial nephritis. Patients should seek immediate medical attention if they experience rash, persistent diarrhea, muscle weakness, or signs of kidney dysfunction.

Lanzul is contraindicated in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking certain interacting medications, and patients for whom alternative acid‑suppression therapy is more appropriate.